ChabnerBA, AmreinPC, DrakerBJ. Chemotherapy of neoplastic diseases. In: Goodman and Gilman's the pharmacological basis of therapeutics. 11th ed.New York, NY: McGraw-Hill Companies, Inc., 2006: 1315–403.
2.
FerreriAJM, ReniM, FoppoliM. High-dose cytarabine plus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomized phase 2 trial. Lancet2009; 374:1512–20.
3.
JaffeN, FarberS, TraggisD. Favourable response of metastatic osteogenic sarcoma to pulse high-dose methotrexate with citrovorum rescue and radiation therapy. Cancer1973; 31:1367–73.
4.
RosenG, TefftM, MartinezA. Combination chemotherapy and radiation therapy in the treatment of metastatic ostiogenic sarcoma. Cancer1975; 35:622–30.
5.
NaranjoCA, BustoU, AbelJG. Empiric delineation of the probability spectrum of adverse drug reactions. Clin Pharmacol Ther1981; 29:267–8.
6.
HirdAE, WilsonJ, SymonsS. Radiation recall dermatitis: case report and review of the literature. Curr Oncol2008; 15:53–62.
7.
AzriaD, MagneN, ZouhairA. Radiation recall: a well recognized but neglected phenomenon. Cancer Treat Rev2005; 31:555–70.
